DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

China flag China · Delayed Price · Currency is CNY
19.82
+0.15 (0.76%)
Mar 6, 2026, 3:00 PM CST
35.29%
Market Cap 22.57B
Revenue (ttm) 26.83B
Net Income (ttm) 1.14B
Shares Out 1.14B
EPS (ttm) 1.01
PE Ratio 19.59
Forward PE 17.56
Dividend 0.68 (3.43%)
Ex-Dividend Date Nov 6, 2025
Volume 3,305,358
Average Volume 5,607,988
Open 19.67
Previous Close 19.67
Day's Range 19.55 - 19.92
52-Week Range 14.45 - 21.78
Beta 0.64
RSI 55.35
Earnings Date Apr 24, 2026

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Sector Healthcare
Founded 1999
Employees 43,532
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2024, SHA:603233's revenue was 26.50 billion, an increase of 8.01% compared to the previous year's 24.53 billion. Earnings were 914.75 million, a decrease of -21.58%.

Financial Statements

News

There is no news available yet.